Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Faster global financial news!
China Pharmaceutical: Subsidiary Obtains Drug Registration Certificate for Nimegoline Tablets
07/01/2026 19:36
Complaint Report
Complaint Report
China Pharmaceutical announced that its wholly-owned subsidiary, Hainan Tongyong Sanyo Pharmaceutical, has received the "Drug Registration Certificate" for nimegoline tablets issued by the National Medical Products Administration. This medication is primarily used to improve low motivation caused by sequelae of cerebral infarction and is also indicated for vascular dementia.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report
Previous: Stock markets in Europe, the U.S., and Asia fell in tandem, while the defense sector bucked the trend to lead gains on the back of favorable policy developments
|
The Speaker of the Turkish Parliament stated that Turkey is closely monitoring every detail of the situation in Aleppo, Syria, and stands ready to provide support to bring an end to the conflict there.: Next
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
Scan to Download App
